Gene therapy clinical trials
Gene: CHMEnsemblGeneIds (GRCh38): ENSG00000188419
EnsemblGeneIds (GRCh37): ENSG00000188419
OMIM: 300390, Gene2Phenotype
CHM is in 6 panels
1 review
Ellen McDonagh (Genomics England Curator)
Added the tag ‘gene-therapy-trial’ as this gene is within the Gene Therapy Panel available here: https://panelapp.genomicsengland.co.uk/panels/412Created: 14 May 2018, 9:29 a.m.
REP1 (encoded by the CHM gene) replacement therapy. Drug: rAAV2.REP1 - trial https://ClinicalTrials.gov/show/NCT01461213. Genetic: AAV-mediated REP1 gene replacement - trial https://ClinicalTrials.gov/show/NCT02407678. Genetic: AAV2-REP1 - https://ClinicalTrials.gov/show/NCT03496012.Created: 2 May 2018, 3:12 p.m.
Phenotypes
Choroideraemia
Details
- Sources
-
- Expert Review Green
- ClinicalTrials.gov
- Phenotypes
-
- Choroideraemia
- OMIM
- 300390
- Clinvar variants
- Variants in CHM
- Penetrance
- None
- Panels with this gene
History Filter Activity
Set penetrance
Ellen McDonagh (Genomics England Curator)Phenotypes for gene CHM were set to Choroideraemia
Added New Source
Ellen McDonagh (Genomics England Curator)CHM was added to Gene therapy clinical trials panel. Sources: ClinicalTrials.gov,Expert Review Green
Created
Ellen McDonagh (Genomics England Curator)CHM was created by Ellen McDonagh